[Date Prev][Date Next][Thread Prev][Thread Next][Date index][Thread index]

From |
Ronan Conroy <rconroy@rcsi.ie> |

To |
statalist@hsphsun2.harvard.edu |

Subject |
Re: st: Number Needed to be Treated (NNT) |

Date |
Thu, 2 Aug 2007 10:11:23 +0100 |

On 1 Aug 2007, at 13:55, Svend Juul wrote:

NNT = 15.230769 (95% CI: 5.0701399; -15.169883) - the negative numbers meaning that exposure to x may prevent low birthweight.

The negative number has the interpretation of Number Needed to Harm (with its minus sign removed), just as a negative Attributable fraction is more usually written as "Prevented fraction in the exposed/population"

Thus the confidence interval in Svend's example runs from an NNT of 5 to an NNH of 15.

The other useful statistic that I recommend is the NTN (number treated needlessly). It is the NNT-1. So if you have to treat 400 people to prevent one event, then the number treated needlessly is 399. A salutary reflection for the average doctor.

P Before printing, think about the environment

=================================

Ronan Conroy

rconroy@rcsi.ie

Royal College of Surgeons in Ireland

120 St Stephen's Green, Dublin 2, Ireland

+353 (0)1 402 2431

+353 (0)87 799 97 95

*

* For searches and help try:

* http://www.stata.com/support/faqs/res/findit.html

* http://www.stata.com/support/statalist/faq

* http://www.ats.ucla.edu/stat/stata/

**Follow-Ups**:**Re: st: Number Needed to be Treated (NNT)***From:*Richard Goldstein <richgold@ix.netcom.com>

**Re: st: Number Needed to be Treated (NNT)***From:*"Anders Alexandersson" <andersalex@gmail.com>

**st: Binomial regression***From:*Constantine Daskalakis <C_Daskalakis@mail.jci.tju.edu>

**References**:**Re: st: Number Needed to be Treated (NNT)***From:*"Svend Juul" <SJ@SOCI.AU.DK>

- Prev by Date:
**st: R-square for each variable** - Next by Date:
**st: RE: R-square for each variable** - Previous by thread:
**R: st: Number Needed to be Treated (NNT)** - Next by thread:
**st: Binomial regression** - Index(es):

© Copyright 1996–2016 StataCorp LP | Terms of use | Privacy | Contact us | What's new | Site index |